Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALKS | AMGN | GILD | CELG | VRTX |
| Company | Alkermes Plc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 27.76 | 333.93 | 83.37 | 108.01 | 483.78 |
| High | 28.41 | 339.00 | 84.52 | 108.59 | 483.78 |
| Low | 27.59 | 331.00 | 82.76 | 107.27 | 473.75 |
| Last | 27.83 | 332.92 | 83.89 | 108.24 | 474.16 |
| Change | +0.09 | +0.12 | +0.84 | +0.11 | -7.10 |
| % Change | +0.32% | +0.04% | +1.01% | +0.10% | -1.48% |
| Volume | 1,401,869 | 1,362,662 | 9,193,441 | 191,230,496 | 837,166 |
| 20-Day Average Volume | 1,346,694 | 1,713,353 | 6,317,389 | 16,188,930 | 965,868 |
| Previous Close | 27.74 | 332.80 | 83.05 | 108.13 | 481.26 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.69 | 329.24 | 79.64 | 108.17 | 480.31 |
| 20-Day Raw Stochastic | 66.50% | 70.13% | 90.49% | 63.25% | 35.60% |
| 20-Day Relative Strength | 54.63% | 55.25% | 71.93% | 64.69% | 47.62% |
| Weighted Alpha | +0.30 | +25.49 | +18.30 | +46.30 | +32.32 |
| Today's Opinion | 56% Buy | 88% Buy | 88% Buy | 100% Buy | 40% Buy |
| Previous Opinion | 72% Buy | 88% Buy | 88% Buy | 100% Buy | 56% Buy |
| Last Month's Opinion | 56% Buy | 72% Buy | 40% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.14% since 09/11/24 | +0.88% since 09/11/24 | +3.69% since 09/11/24 | -1.97% since 11/13/19 | +0.01% since 09/11/24 |
| Low | 26.01 on 09/12/24 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 468.46 on 09/12/24 |
| High | 28.47 on 09/17/24 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 110.53 on 11/14/19 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | +1.54% since 08/16/24 | +3.56% since 08/16/24 | +13.76% since 08/16/24 | +5.14% since 10/18/19 | -0.54% since 08/16/24 |
| Low | 25.65 on 09/10/24 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 102.40 on 10/21/19 | 460.69 on 09/11/24 |
| High | 28.69 on 08/27/24 | 338.80 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +13.31% since 06/18/24 | +8.79% since 06/18/24 | +32.91% since 06/18/24 | +13.63% since 08/20/19 | +1.60% since 06/18/24 |
| Low | 22.90 on 07/10/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 458.04 on 08/13/24 |
| High | 28.95 on 07/26/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | +0.51% since 03/18/24 | +22.88% since 03/18/24 | +14.56% since 03/18/24 | +14.14% since 05/20/19 | +15.41% since 03/18/24 |
| Low | 22.90 on 07/10/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 391.01 on 04/18/24 |
| High | 28.95 on 07/26/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,694,191 | 178,525,568 | 103,468,096 | 77,035,920 | 124,190,592 |
| Shares Outstanding, K | 169,221 | 536,435 | 1,245,853 | 711,714 | 258,053 |
| Annual Sales | 1,663,410,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | 355,760,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 399,130,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 2,645,600,000 |
| Last Quarter Net Income | 91,360,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -3,593,600,000 |
| 60-Month Beta | 0.46 | 0.61 | 0.18 | 1.41 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.72 on 07/24/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | -12.83 on 08/01/24 |
| Latest Earnings Date | 10/23/24 | 10/29/24 | 11/05/24 | 10/31/19 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 16.09 | 18.02 | 17.69 | 10.99 | 0.00 |